{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:04:00Z","timestamp":1794081840861,"version":"4.8.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12015-025-10884-x","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:49:04Z","timestamp":1745390944000},"page":"1160-1185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Can Stem Cell Therapy Revolutionize Ocular Disease Treatment? A Critical Review of Preclinical and Clinical Advances"],"prefix":"10.1007","volume":"21","author":[{"given":"Kai-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi-Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-3411","authenticated-orcid":false,"given":"Chi-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"10884_CR1","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.2147\/OPTH.S258783","volume":"14","author":"DL Demmin","year":"2020","unstructured":"Demmin, D. L., & Silverstein, S. M. (2020). Visual impairment and mental health: unmet needs and treatment Options. Clinical Ophthalmology, 14, 4229\u20134251. https:\/\/doi.org\/10.2147\/OPTH.S258783","journal-title":"Clinical Ophthalmology"},{"issue":"2","key":"10884_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L., Su, X., Li, X., et al. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. The Lancet Global Health, 2(2), e106\u2013e116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1","journal-title":"The Lancet Global Health"},{"issue":"4","key":"10884_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell Aug"},{"issue":"9817","key":"10884_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/s0140-6736(12)60028-2","volume":"379","author":"SD Schwartz","year":"2012","unstructured":"Schwartz, S. D., Hubschman, J. P., Heilwell, G., et al. (2012). Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet, 379(9817), 713\u2013720. https:\/\/doi.org\/10.1016\/s0140-6736(12)60028-2","journal-title":"Lancet"},{"issue":"4","key":"10884_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.4114","volume":"379","author":"L da Cruz","year":"2018","unstructured":"da Cruz, L., Fynes, K., Georgiadis, O., et al. (2018). Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol, 379(4), 328\u2013337. https:\/\/doi.org\/10.1038\/nbt.4114","journal-title":"Nat Biotechnol"},{"key":"10884_CR6","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2147\/cia.S47350","volume":"8","author":"Y Hu","year":"2013","unstructured":"Hu, Y., Tan, H. B., Wang, X. M., Rong, H., Cui, H. P., & Cui, H. (2013). Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma. Clinical interventions in Aging, 8, 1467\u20131470. https:\/\/doi.org\/10.2147\/cia.S47350","journal-title":"Clinical interventions in Aging"},{"issue":"1","key":"10884_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1517\/14712598.2016.1093110","volume":"16","author":"H Klassen","year":"2016","unstructured":"Klassen, H. (2016). Stem cells in clinical trials for treatment of retinal degeneration. Expert Opinion on Biological Therapy, 16(1), 7\u201314. https:\/\/doi.org\/10.1517\/14712598.2016.1093110","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"4","key":"10884_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrc3034","volume":"11","author":"U Ben-David","year":"2011","unstructured":"Ben-David, U., & Benvenisty, N. (2011). The tumorigenicity of human embryonic and induced pluripotent stem cells. Nature Reviews Cancer, 11(4), 268\u2013277. https:\/\/doi.org\/10.1038\/nrc3034","journal-title":"Nature Reviews Cancer"},{"issue":"4","key":"10884_CR9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/sctm.16-0428","volume":"6","author":"B Mead","year":"2017","unstructured":"Mead, B., & Tomarev, S. (2017). Bone marrow-derived mesenchymal stem cells-derived exosomes promote survival of retinal ganglion cells through miRNA-dependent mechanisms. Stem Cells Translational Medicine, 6(4), 1273\u20131285. https:\/\/doi.org\/10.1002\/sctm.16-0428","journal-title":"Stem Cells Translational Medicine"},{"key":"10884_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2019.03.001","volume":"71","author":"G Gagliardi","year":"2019","unstructured":"Gagliardi, G., Ben, M., Barek, K., & Goureau, O. (2019). Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: A pluripotent stem cell-based approach. Prog Retin Eye Res, 71, 1\u201325. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.03.001","journal-title":"Prog Retin Eye Res"},{"key":"10884_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.exer.2018.07.019","volume":"177","author":"S Bobba","year":"2018","unstructured":"Bobba, S., Di Girolamo, N., Munsie, M., et al. (2018). The current state of stem cell therapy for ocular disease. Exp Eye Res, 177, 65\u201375. https:\/\/doi.org\/10.1016\/j.exer.2018.07.019","journal-title":"Exp Eye Res"},{"issue":"10","key":"10884_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1089\/jop.2013.0028","volume":"29","author":"DD Eveleth","year":"2013","unstructured":"Eveleth, D. D. (2013). Cell-based therapies for ocular disease. J Ocul Pharmacol Ther, 29(10), 844\u2013854. https:\/\/doi.org\/10.1089\/jop.2013.0028","journal-title":"J Ocul Pharmacol Ther"},{"key":"10884_CR13","doi-asserted-by":"publisher","first-page":"15015","DOI":"10.1038\/celldisc.2015.15","volume":"1","author":"L Wang","year":"2015","unstructured":"Wang, L., Cao, J., Wang, Y., Lan, T., Liu, L., Wang, W., Jin, N., Gong, J., Zhang, C., Teng, F., Yan, G., Li, C., Li, J., Wan, H., Hu, B., Li, W., Zhao, X., Qi, Z., Zhao, T., & Zhou, Q. (2015). Immunogenicity and functional evaluation of iPSC-derived organs for transplantation. Cell Discovery, 1, 15015. https:\/\/doi.org\/10.1038\/celldisc.2015.15","journal-title":"Cell Discovery"},{"key":"10884_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biomaterials.2016.07.028","volume":"105","author":"P Moshayedi","year":"2016","unstructured":"Moshayedi, P., Nih, L. R., Llorente, I. L., Berg, A. R., Cinkornpumin, J., Lowry, W. E., Segura, T., & Carmichael, S. T. (2016). Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain. Biomaterials, 105, 145\u2013155. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.07.028","journal-title":"Biomaterials"},{"key":"10884_CR15","doi-asserted-by":"publisher","first-page":"122091","DOI":"10.1016\/j.biomaterials.2023.122091","volume":"296","author":"N Lagneau","year":"2023","unstructured":"Lagneau, N., Tournier, P., Nativel, F., Maugars, Y., Guicheux, J., Le Visage, C., & Delplace, V. (2023). Harnessing cell-material interactions to control stem cell secretion for osteoarthritis treatment. Biomaterials, 296, 122091. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122091","journal-title":"Biomaterials"},{"issue":"3","key":"10884_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/ico.0000000000001820","volume":"38","author":"SX Deng","year":"2019","unstructured":"Deng, S. X., Borderie, V., Chan, C. C., et al. (2019). Global consensus on definition, classification, diagnosis, and staging of limbal stem cell deficiency. Cornea, 38(3), 364\u2013375. https:\/\/doi.org\/10.1097\/ico.0000000000001820","journal-title":"Cornea"},{"issue":"10","key":"10884_CR17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/ico.0000000000002358","volume":"39","author":"SX Deng","year":"2020","unstructured":"Deng, S. X., Kruse, F., Gomes, J. A. P., et al. (2020). Global consensus on the management of limbal stem cell deficiency. Cornea, 39(10), 1291\u20131302. https:\/\/doi.org\/10.1097\/ico.0000000000002358","journal-title":"Cornea"},{"issue":"3","key":"10884_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/08820530902801478","volume":"24","author":"P Lim","year":"2009","unstructured":"Lim, P., Fuchsluger, T. A., & Jurkunas, U. V. (2009). Limbal stem cell deficiency and corneal neovascularization. Semin Ophthalmol, 24(3), 139\u2013148. https:\/\/doi.org\/10.1080\/08820530902801478","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"10884_CR19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ophtha.2009.01.005","volume":"116","author":"M Pauklin","year":"2009","unstructured":"Pauklin, M., Steuhl, K. P., & Meller, D. (2009). Characterization of the corneal surface in limbal stem cell deficiency and after transplantation of cultivated limbal epithelium. Ophthalmology, 116(6), 1048\u20131056. https:\/\/doi.org\/10.1016\/j.ophtha.2009.01.005","journal-title":"Ophthalmology"},{"key":"10884_CR20","doi-asserted-by":"publisher","unstructured":"Toshida, H., Kasahara, T., Kiriyama, M., et al. (2023). Early clinical outcomes of the first commercialized human autologous ex vivo cultivated oral mucosal epithelial cell transplantation for limbal stem cell deficiency: Two case reports and literature review.\u00a0International Journal of Molecular Sciences, 18(10). https:\/\/doi.org\/10.3390\/ijms24108926","DOI":"10.3390\/ijms24108926"},{"key":"10884_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ajo.2022.03.015","volume":"239","author":"U Jurkunas","year":"2022","unstructured":"Jurkunas, U., Johns, L., & Armant, M. (2022). Cultivated autologous limbal epithelial cell transplantation: New frontier in the treatment of limbal stem cell deficiency. Am J Ophthalmol, 239, 244\u2013268. https:\/\/doi.org\/10.1016\/j.ajo.2022.03.015","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10884_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/bjophthalmol-2020-318642","volume":"106","author":"P Thokala","year":"2022","unstructured":"Thokala, P., Singh, A., Singh, V. K., et al. (2022). Economic, clinical and social impact of simple limbal epithelial transplantation for limbal stem cell deficiency. Br J Ophthalmol, 106(7), 923\u2013928. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318642","journal-title":"Br J Ophthalmol"},{"key":"10884_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000315020","volume":"45","author":"M Pauklin","year":"2010","unstructured":"Pauklin, M., Fuchsluger, T. A., Westekemper, H., Steuhl, K. P., & Meller, D. (2010). Midterm results of cultivated autologous and allogeneic limbal epithelial transplantation in limbal stem cell deficiency. Developments in Ophthalmology, 45, 57\u201370. https:\/\/doi.org\/10.1159\/000315020","journal-title":"Developments in Ophthalmology"},{"issue":"2","key":"10884_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/bjo.2009.173716","volume":"95","author":"R Tandon","year":"2011","unstructured":"Tandon, R., Gupta, N., Kalaivani, M., Sharma, N., Titiyal, J. S., & Vajpayee, R. B. (2011). Amniotic membrane transplantation as an adjunct to medical therapy in acute ocular burns. Br J Ophthalmol, 95(2), 199\u2013204. https:\/\/doi.org\/10.1136\/bjo.2009.173716","journal-title":"Br J Ophthalmol"},{"issue":"9057","key":"10884_CR25","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/s0140-6736(96)11188-0","volume":"349","author":"G Pellegrini","year":"1997","unstructured":"Pellegrini, G., Traverso, C. E., Franzi, A. T., Zingirian, M., Cancedda, R., & De Luca, M. (1997). Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet, 349(9057), 990\u2013993. https:\/\/doi.org\/10.1016\/s0140-6736(96)11188-0","journal-title":"Lancet"},{"issue":"9","key":"10884_CR26","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1097\/00007890-200111150-00002","volume":"15","author":"P Rama","year":"2001","unstructured":"Rama, P., Bonini, S., Lambiase, A., et al. (2001). Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation, 15(9), 1478\u20131485. https:\/\/doi.org\/10.1097\/00007890-200111150-00002","journal-title":"Transplantation"},{"key":"10884_CR27","doi-asserted-by":"publisher","unstructured":"Jackson, C. J., Myklebust Ern\u00f8, I. T., Ringstad, H., T\u00f8nseth, K. A., Dartt, D. A., & Utheim, T. P. (2020). Simple limbal epithelial transplantation: Current status and future perspectives.\u00a0Stem Cells Translational Medicine, 9(3), 316\u2013327. https:\/\/doi.org\/10.1002\/sctm.19-0203","DOI":"10.1002\/sctm.19-0203"},{"issue":"6","key":"10884_CR28","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.survophthal.2018.05.003","volume":"63","author":"D Borroni","year":"2018","unstructured":"Borroni, D., Wowra, B., Romano, V., et al. (2018). Simple limbal epithelial transplantation: A review on current approach and future directions. Surv Ophthalmol, 63(6), 869\u2013874. https:\/\/doi.org\/10.1016\/j.survophthal.2018.05.003","journal-title":"Surv Ophthalmol"},{"key":"10884_CR29","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jtos.2024.10.007","volume":"34","author":"N Sharma","year":"2024","unstructured":"Sharma, N., Venugopal, R., Mohanty, S., et al. (2024). Simple limbal epithelial transplantation versus cultivated limbal epithelial transplantation in ocular burns. Ocul Surf, 34, 504\u2013509. https:\/\/doi.org\/10.1016\/j.jtos.2024.10.007","journal-title":"Ocul Surf"},{"issue":"12","key":"10884_CR30","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.4103\/ijo.IJO_1891_22","volume":"70","author":"SG Datar","year":"2022","unstructured":"Datar, S. G., & Godse, G. N. (2022). Modified supportive simple limbal epithelial transplantation (M-SLET): A surgical technique modified for limbal stem cell deficiency. Indian J Ophthalmol, 70(12), 4434\u20134437. https:\/\/doi.org\/10.4103\/ijo.IJO_1891_22","journal-title":"Indian J Ophthalmol"},{"key":"10884_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jtos.2021.06.012","volume":"22","author":"P Prabhasawat","year":"2021","unstructured":"Prabhasawat, P., Chirapapaisan, C., Ngowyutagon, P., et al. (2021). Efficacy and outcome of simple limbal epithelial transplantation for limbal stem cell deficiency verified by epithelial phenotypes integrated with clinical evaluation. Ocul Surf, 22, 27\u201337. https:\/\/doi.org\/10.1016\/j.jtos.2021.06.012","journal-title":"Ocul Surf"},{"issue":"1","key":"10884_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12886-024-03297-w","volume":"24","author":"M Ahadi","year":"2024","unstructured":"Ahadi, M., Ramin, S., Abbasi, A., Tahmouri, H., & Hosseini, S. B. (2024). Mini review: Human clinical studies of stem cell therapy in keratoconus. BMC Ophthalmol, 24(1), 35. https:\/\/doi.org\/10.1186\/s12886-024-03297-w","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"10884_CR33","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/ico.0000000000001228","volume":"36","author":"JL Del Ali\u00f3","year":"2017","unstructured":"Del Ali\u00f3, J. L., El Zarif, M., de Miguel, M. P., et al. (2017). Cellular therapy with human autologous Adipose-Derived adult stem cells for advanced keratoconus. Cornea, 36(8), 952\u2013960. https:\/\/doi.org\/10.1097\/ico.0000000000001228","journal-title":"Cornea"},{"key":"10884_CR34","doi-asserted-by":"publisher","unstructured":"Ong, H. S., Riau, A. K., Yam, G. H., et al. (2023). Mesenchymal stem cell exosomes as Immunomodulatory therapy for corneal scarring.\u00a0International Journal of Molecular Sciences, 18(8). https:\/\/doi.org\/10.3390\/ijms24087456","DOI":"10.3390\/ijms24087456"},{"key":"10884_CR35","doi-asserted-by":"publisher","unstructured":"Jhanji, V., Santra, M., Riau, A. K., et al. (2022). Combined therapy using human corneal stromal stem cells and quiescent keratocytes to prevent corneal scarring after injury.\u00a0International Journal of Molecular Sciences,\u00a023(13). https:\/\/doi.org\/10.3390\/ijms23136980","DOI":"10.3390\/ijms23136980"},{"issue":"12","key":"10884_CR36","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1167\/iovs.18-24803","volume":"1","author":"R Samaeekia","year":"2018","unstructured":"Samaeekia, R., Rabiee, B., Putra, I., et al. (2018). Effect of human corneal mesenchymal stromal Cell-derived exosomes on corneal epithelial wound healing. Invest Ophthalmol Vis Sci, 1(12), 5194\u20135200. https:\/\/doi.org\/10.1167\/iovs.18-24803","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9817","key":"10884_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s0140-6736(12)60118-4","volume":"379","author":"A Atala","year":"2012","unstructured":"Atala, A. (2012). Human embryonic stem cells: Early hints on safety and efficacy. Lancet, 379(9817), 689\u2013690. https:\/\/doi.org\/10.1016\/s0140-6736(12)60118-4","journal-title":"Lancet"},{"issue":"7","key":"10884_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tins.2013.03.006","volume":"36","author":"AJ Carr","year":"2013","unstructured":"Carr, A. J., Smart, M. J., Ramsden, C. M., Powner, M. B., da Cruz, L., & Coffey, P. J. (2013). Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci, 36(7), 385\u2013395. https:\/\/doi.org\/10.1016\/j.tins.2013.03.006","journal-title":"Trends Neurosci"},{"key":"10884_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.004","volume":"48","author":"H Nazari","year":"2015","unstructured":"Nazari, H., Zhang, L., Zhu, D., et al. (2015). Stem cell based therapies for age-related macular degeneration: The promises and the challenges. Prog Retin Eye Res, 48, 1\u201339. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.004","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10884_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/1574888x15666191218094020","volume":"15","author":"HC O\u2019Neill","year":"2020","unstructured":"O\u2019Neill, H. C., Limnios, I. J., & Barnett, N. L. (2020). Advancing a stem cell therapy for Age-Related macular degeneration. Curr Stem Cell Res Ther, 15(2), 89\u201397. https:\/\/doi.org\/10.2174\/1574888x15666191218094020","journal-title":"Curr Stem Cell Res Ther"},{"issue":"2","key":"10884_CR41","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1167\/iovs.13-13481","volume":"55","author":"K Bharti","year":"2014","unstructured":"Bharti, K., Rao, M., Hull, S. C., et al. (2014). Developing cellular therapies for retinal degenerative diseases. Invest Ophthalmol Vis Sci, 55(2), 1191\u20131202. https:\/\/doi.org\/10.1167\/iovs.13-13481","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9967","key":"10884_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/s0140-6736(14)61376-3","volume":"7","author":"SD Schwartz","year":"2015","unstructured":"Schwartz, S. D., Regillo, C. D., Lam, B. L., et al. (2015). Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: Follow-up of two open-label phase 1\/2 studies. Lancet, 7(9967), 509\u2013516. https:\/\/doi.org\/10.1016\/s0140-6736(14)61376-3","journal-title":"Lancet"},{"key":"10884_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40942-019-0158-y","volume":"5","author":"PE Ludwig","year":"2019","unstructured":"Ludwig, P. E., Freeman, S. C., & Janot, A. C. (2019). Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa. Int J Retina Vitreous, 5, 7. https:\/\/doi.org\/10.1186\/s40942-019-0158-y","journal-title":"Int J Retina Vitreous"},{"key":"10884_CR44","doi-asserted-by":"publisher","unstructured":"Yang, Y. P., Hsiao, Y. J., Chang, K. J., et al. (2022). Pluripotent stem cells in clinical cell transplantation: Focusing on induced pluripotent stem cell-Derived RPE cell therapy in Age-Related macular degeneration.\u00a0International Journal of Molecular Sciences, 23(22). https:\/\/doi.org\/10.3390\/ijms232213794","DOI":"10.3390\/ijms232213794"},{"key":"10884_CR45","doi-asserted-by":"publisher","unstructured":"Liu, W., Liu, S., Li, P., & Yao, K. (2022). Retinitis pigmentosa: Progress in molecular pathology and biotherapeutical strategies.\u00a0International Journal of Molecular Sciences,\u00a023(9). https:\/\/doi.org\/10.3390\/ijms23094883","DOI":"10.3390\/ijms23094883"},{"key":"10884_CR46","doi-asserted-by":"publisher","unstructured":"Vingolo, E. M., Mascolo, S., Miccich\u00e8, F., & Manco, G. (2024). Retinitis pigmentosa: From pathomolecular mechanisms to therapeutic strategies. Medicina (Kaunas), 60(1). https:\/\/doi.org\/10.3390\/medicina60010189","DOI":"10.3390\/medicina60010189"},{"issue":"3","key":"10884_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0039-6257(88)90085-9","volume":"33","author":"RA Pagon","year":"1988","unstructured":"Pagon, R. A. (1988). Retinitis pigmentosa. Surv Ophthalmol, 33(3), 137\u2013177. https:\/\/doi.org\/10.1016\/0039-6257(88)90085-9","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"10884_CR48","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.18240\/ijo.2024.07.22","volume":"17","author":"XY Qi","year":"2024","unstructured":"Qi, X. Y., Mi, C. H., Cao, D. R., Chen, X. Q., & Zhang, P. (2024). Retinitis pigmentosa and stem cell therapy. Int J Ophthalmol, 17(7), 1363\u20131369. https:\/\/doi.org\/10.18240\/ijo.2024.07.22","journal-title":"Int J Ophthalmol"},{"key":"10884_CR49","doi-asserted-by":"publisher","unstructured":"Wu, K. Y., Kulbay, M., Toameh, D., Xu, A. Q., Kalevar, A., & Tran, S. D. (2023). Retinitis pigmentosa: Novel therapeutic targets and drug development. Pharmaceutics, 15(2). https:\/\/doi.org\/10.3390\/pharmaceutics15020685","DOI":"10.3390\/pharmaceutics15020685"},{"issue":"12","key":"10884_CR50","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.stem.2023.11.004","volume":"30","author":"Y Hirami","year":"2023","unstructured":"Hirami, Y., Mandai, M., Sugita, S., et al. (2023). Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa. Cell Stem Cell, 30(12), 1585-1596e6. https:\/\/doi.org\/10.1016\/j.stem.2023.11.004","journal-title":"Cell Stem Cell"},{"key":"10884_CR51","doi-asserted-by":"publisher","unstructured":"Ma, C., Jin, K., & Jin, Z. B. (2022). Generation of human patient iPSC-derived retinal organoids to model retinitis pigmentosa.\u00a0Journal of Visualized Experiments, (184). https:\/\/doi.org\/10.3791\/64045","DOI":"10.3791\/64045"},{"issue":"5","key":"10884_CR52","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s11427-023-2531-3","volume":"67","author":"CJ Zhang","year":"2024","unstructured":"Zhang, C. J., & Jin, Z. B. (2024). Turning point of organoid transplantation: First-in-human trial of iPSC-derived retinal organoid grafting in patients with retinitis pigmentosa. Sci China Life Sci, 67(5), 1082\u20131084. https:\/\/doi.org\/10.1007\/s11427-023-2531-3","journal-title":"Sci China Life Sci"},{"key":"10884_CR53","doi-asserted-by":"publisher","unstructured":"Limoli, P. G., Vingolo, E. M., Limoli, C., & Nebbioso, M. (2020). Antioxidant and biological properties of mesenchymal cells used for therapy in retinitis pigmentosa. Antioxidants (Basel), 9(10). https:\/\/doi.org\/10.3390\/antiox9100983","DOI":"10.3390\/antiox9100983"},{"issue":"1","key":"10884_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13287-020-02122-7","volume":"12","author":"A Tuekprakhon","year":"2021","unstructured":"Tuekprakhon, A., Sangkitporn, S., Trinavarat, A., et al. (2021). Intravitreal autologous mesenchymal stem cell transplantation: A non-randomized phase I clinical trial in patients with retinitis pigmentosa. Stem Cell Res Ther, 12(1), 52. https:\/\/doi.org\/10.1186\/s13287-020-02122-7","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10884_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13287-016-0432-y","volume":"7","author":"A Oner","year":"2016","unstructured":"Oner, A., Gonen, Z. B., Sinim, N., Cetin, M., & Ozkul, Y. (2016). Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: A phase I clinical safety study. Stem Cell Res Ther, 7(1), 178. https:\/\/doi.org\/10.1186\/s13287-016-0432-y","journal-title":"Stem Cell Res Ther"},{"issue":"16","key":"10884_CR56","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1089\/scd.2020.0037","volume":"29","author":"T Zhao","year":"2020","unstructured":"Zhao, T., Liang, Q., Meng, X., et al. (2020). Intravenous infusion of umbilical cord mesenchymal stem cells maintains and partially improves visual function in patients with advanced retinitis pigmentosa. Stem Cells Dev, 29(16), 1029\u20131037. https:\/\/doi.org\/10.1089\/scd.2020.0037","journal-title":"Stem Cells Dev"},{"key":"10884_CR57","doi-asserted-by":"publisher","unstructured":"Artero-Castro, A., Long, K., Bassett, A., et al. (2021). Gene correction recovers phagocytosis in retinal pigment epithelium derived from retinitis pigmentosa-Human-Induced pluripotent stem cells.\u00a0International Journal of Molecular Sciences, 22(4). https:\/\/doi.org\/10.3390\/ijms22042092","DOI":"10.3390\/ijms22042092"},{"key":"10884_CR58","doi-asserted-by":"publisher","first-page":"1077669","DOI":"10.3389\/fendo.2022.1077669","volume":"13","author":"TE Tan","year":"2022","unstructured":"Tan, T. E., & Wong, T. Y. (2022). Diabetic retinopathy: Looking forward to 2030. Front Endocrinol (Lausanne), 13, 1077669. https:\/\/doi.org\/10.3389\/fendo.2022.1077669","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10884_CR59","doi-asserted-by":"publisher","unstructured":"Cheung, N., Mitchell, P., & Wong, T. Y. (2010). Diabetic retinopathy. Lancet, 376(9735):124\u2013\u200936. https:\/\/doi.org\/10.1016\/s0140-6736(09)62124-3","DOI":"10.1016\/s0140-6736(09)62124-3"},{"issue":"5","key":"10884_CR60","doi-asserted-by":"publisher","first-page":"101140","DOI":"10.1016\/j.disamonth.2021.101140","volume":"67","author":"S Chaudhary","year":"2021","unstructured":"Chaudhary, S., Zaveri, J., & Becker, N. (2021). Proliferative diabetic retinopathy (PDR). Dis Mon, 67(5), 101140. https:\/\/doi.org\/10.1016\/j.disamonth.2021.101140","journal-title":"Dis Mon"},{"issue":"5","key":"10884_CR61","doi-asserted-by":"publisher","first-page":"101139","DOI":"10.1016\/j.disamonth.2021.101139","volume":"67","author":"D Danek","year":"2021","unstructured":"Danek, D., Larsen, B., & Anderson-Nelson, S. (2021). Non-proliferative diabetic retinopathy. Dis Mon, 67(5), 101139. https:\/\/doi.org\/10.1016\/j.disamonth.2021.101139","journal-title":"Dis Mon"},{"key":"10884_CR62","doi-asserted-by":"publisher","unstructured":"Bryl, A., Mrugacz, M., Falkowski, M., & Zorena, K. (2022). The effect of diet and lifestyle on the course of diabetic Retinopathy-A review of the literature. Nutrients, 16(6). https:\/\/doi.org\/10.3390\/nu14061252","DOI":"10.3390\/nu14061252"},{"issue":"12","key":"10884_CR63","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/s41433-019-0494-z","volume":"33","author":"M Saw","year":"2019","unstructured":"Saw, M., Wong, V. W., Ho, I. V., & Liew, G. (2019). New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy. Eye (Lond), 33(12), 1842\u20131851. https:\/\/doi.org\/10.1038\/s41433-019-0494-z","journal-title":"Eye (Lond)"},{"issue":"3","key":"10884_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/0115733998259940231105200251","volume":"21","author":"R Singh","year":"2025","unstructured":"Singh, R., Walia, A., Kaur, J., Kumar, P., Verma, I., & Rani, N. (2025). Diabetic Retinopathy - Pathophysiology to treatment: A review. Current Diabetes Review, 21(3), 58\u201367. https:\/\/doi.org\/10.2174\/0115733998259940231105200251","journal-title":"Current Diabetes Review"},{"key":"10884_CR65","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.biomaterials.2019.01.016","volume":"197","author":"B Mathew","year":"2019","unstructured":"Mathew, B., Ravindran, S., Liu, X., et al. (2019). Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion. Biomaterials, 197, 146\u2013160. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.01.016","journal-title":"Biomaterials"},{"key":"10884_CR66","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.bioactmat.2023.11.008","volume":"33","author":"F Sun","year":"2024","unstructured":"Sun, F., Sun, Y., Wang, X., et al. (2024). Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1\u03b1\/EZH2\/PGC-1\u03b1 pathway. Bioact Mater, 33, 444\u2013459. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.11.008","journal-title":"Bioact Mater"},{"issue":"1","key":"10884_CR67","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/stmcls\/sxad078","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Yao, G., Tong, J., et al. (2024). MSC-Derived small extracellular vesicles alleviate diabetic retinopathy by delivering miR-22-3p to inhibit NLRP3 inflammasome activation. Stem Cells, 42(1), 64\u201375. https:\/\/doi.org\/10.1093\/stmcls\/sxad078","journal-title":"Stem Cells"},{"issue":"10","key":"10884_CR68","doi-asserted-by":"publisher","first-page":"752","DOI":"10.14740\/jocmr3581w","volume":"10","author":"L Hu","year":"2018","unstructured":"Hu, L., Dai, S. C., Luan, X., Chen, J., & Cannavicci, A. (2018). Dysfunction and therapeutic potential of endothelial progenitor cells in diabetes mellitus. J Clin Med Res, 10(10), 752\u2013757. https:\/\/doi.org\/10.14740\/jocmr3581w","journal-title":"J Clin Med Res"},{"key":"10884_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fendo.2014.00044","volume":"5","author":"N Lois","year":"2014","unstructured":"Lois, N., McCarter, R. V., O\u2019Neill, C., Medina, R. J., & Stitt, A. W. (2014). Endothelial progenitor cells in diabetic retinopathy. Front Endocrinol (Lausanne), 5, 44. https:\/\/doi.org\/10.3389\/fendo.2014.00044","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"10884_CR70","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jdiacomp.2018.06.015","volume":"32","author":"Y Shao","year":"2018","unstructured":"Shao, Y., Li, X., Wood, J. W., & Ma, J. X. (2018). Mitochondrial dysfunctions, endothelial progenitor cells and diabetic retinopathy. J Diabetes Complications, 32(10), 966\u2013973. https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.06.015","journal-title":"J Diabetes Complications"},{"key":"10884_CR71","first-page":"1680","volume":"14","author":"JM Lopes de Faria","year":"2008","unstructured":"Lopes de Faria, J. M., Silva, K. C., Boer, P. A., et al. (2008). A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension. Mol Vis, 14, 1680\u20131691.","journal-title":"Mol Vis"},{"issue":"9","key":"10884_CR72","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.5966\/sctm.2015-0342","volume":"5","author":"JM Kim","year":"2016","unstructured":"Kim, J. M., Hong, K. S., Song, W. K., et al. (2016). Perivascular progenitor cells derived from human embryonic stem cells exhibit functional characteristics of pericytes and improve the retinal vasculature in a rodent model of diabetic retinopathy. Stem Cells Transl Med, 5(9), 1268\u20131276. https:\/\/doi.org\/10.5966\/sctm.2015-0342","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10884_CR73","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1038\/s41467-022-33773-0","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu, H., Stepicheva, N. A., Ghosh, S., et al. (2022). Reducing Akt2 in retinal pigment epithelial cells causes a compensatory increase in Akt1 and attenuates diabetic retinopathy. Nat Commun, 13(1), 6045. https:\/\/doi.org\/10.1038\/s41467-022-33773-0","journal-title":"Nat Commun"},{"key":"10884_CR74","doi-asserted-by":"publisher","unstructured":"Jayaram, H., Kolko, M., Friedman, D. S., & Gazzard, G. (2023). Glaucoma: now and beyond. Lancet, 402(10414):1788\u20131801. https:\/\/doi.org\/10.1016\/s0140-6736(23)01289-8","DOI":"10.1016\/s0140-6736(23)01289-8"},{"key":"10884_CR75","doi-asserted-by":"publisher","unstructured":"Schuster, A. K., Wagner, F. M., Pfeiffer, N., & Hoffmann, E. M. (2021). Jul. Risk factors for open-angle glaucoma and recommendations for glaucoma screening. Ophthalmologe, 118(Suppl 2):145\u2013152. Risikofaktoren f\u00fcr das Offenwinkelglaukom und Empfehlungen zur Glaukomfr\u00fcherkennung. https:\/\/doi.org\/10.1007\/s00347-021-01378-5","DOI":"10.1007\/s00347-021-01378-5"},{"issue":"3","key":"10884_CR76","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/08820538.2020.1781906","volume":"35","author":"AM Elhusseiny","year":"2020","unstructured":"Elhusseiny, A. M., & VanderVeen, D. K. (2020). Outcomes of glaucoma drainage devices in childhood glaucoma. Semin Ophthalmol, 35(3), 194\u2013204. https:\/\/doi.org\/10.1080\/08820538.2020.1781906","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"10884_CR77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","volume":"130","author":"G Gazzard","year":"2023","unstructured":"Gazzard, G., Konstantakopoulou, E., Garway-Heath, D., et al. (2023). Laser in glaucoma and ocular hypertension (LiGHT) trial: Six-Year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension. Ophthalmology, 130(2), 139\u2013151. https:\/\/doi.org\/10.1016\/j.ophtha.2022.09.009","journal-title":"Ophthalmology"},{"issue":"1","key":"10884_CR78","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/bjophthalmol-2021-319379","volume":"107","author":"N Congdon","year":"2023","unstructured":"Congdon, N., Azuara-Blanco, A., Solberg, Y., et al. (2023). Direct selective laser trabeculoplasty in open angle glaucoma study design: A multicentre, randomised, controlled, investigator-masked trial (GLAUrious). Br J Ophthalmol, 107(1), 62\u201365. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319379","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10884_CR79","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ophtha.2022.07.003","volume":"129","author":"SJ Gedde","year":"2022","unstructured":"Gedde, S. J., Feuer, W. J., Lim, K. S., et al. (2022). Treatment outcomes in the primary tube versus trabeculectomy study after 5 years of Follow-up. Ophthalmology, 129(12), 1344\u20131356. https:\/\/doi.org\/10.1016\/j.ophtha.2022.07.003","journal-title":"Ophthalmology"},{"key":"10884_CR80","doi-asserted-by":"publisher","first-page":"101063","DOI":"10.1016\/j.preteyeres.2022.101063","volume":"90","author":"SJ Coulon","year":"2022","unstructured":"Coulon, S. J., Schuman, J. S., Du, Y., Bahrani Fard, M. R., Ethier, C. R., & Stamer, W. D. (2022). A novel glaucoma approach: Stem cell regeneration of the trabecular meshwork. Prog Retin Eye Res, 90, 101063. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101063","journal-title":"Prog Retin Eye Res"},{"key":"10884_CR81","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.pbr.2020.05.026","volume":"257","author":"ZQ Hua","year":"2020","unstructured":"Hua, Z. Q., Liu, H., Wang, N., & Jin, Z. B. (2020). Towards stem cell-based neuronal regeneration for glaucoma. Progress in Brain Research, 257, 99\u2013118. https:\/\/doi.org\/10.1016\/bs.pbr.2020.05.026","journal-title":"Progress in Brain Research"},{"key":"10884_CR82","doi-asserted-by":"publisher","unstructured":"Daliri, K., Ljubimov, A. V., Hekmatimoghaddam, S., & Glaucoma (2017). Stem cells, and gene therapy: Where are we now??\u00a0International Journal of Stem Cells, 10(2), 119\u2013128. https:\/\/doi.org\/10.15283\/ijsc17029","DOI":"10.15283\/ijsc17029"},{"issue":"6","key":"10884_CR83","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/mot.0000000000000360","volume":"21","author":"N Murphy","year":"2016","unstructured":"Murphy, N., Lynch, K., Lohan, P., Treacy, O., & Ritter, T. (2016). Mesenchymal stem cell therapy to promote corneal allograft survival: Current status and pathway to clinical translation. Curr Opin Organ Transplant, 21(6), 559\u2013567. https:\/\/doi.org\/10.1097\/mot.0000000000000360","journal-title":"Curr Opin Organ Transplant"},{"issue":"6","key":"10884_CR84","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/03008207.2016.1215442","volume":"57","author":"LE Clements","year":"2016","unstructured":"Clements, L. E., Garvican, E. R., Dudhia, J., & Smith, R. K. (2016). Modulation of mesenchymal stem cell genotype and phenotype by extracellular matrix proteins. Connect Tissue Res, 57(6), 443\u2013453. https:\/\/doi.org\/10.1080\/03008207.2016.1215442","journal-title":"Connect Tissue Res"},{"issue":"4","key":"10884_CR85","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1167\/iovs.09-4509","volume":"51","author":"TV Johnson","year":"2010","unstructured":"Johnson, T. V., Bull, N. D., Hunt, D. P., Marina, N., Tomarev, S. I., & Martin, K. R. (2010). Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Investigative Ophthalmology & Visual Science, 51(4), 2051\u20132059.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"25","key":"10884_CR86","doi-asserted-by":"publisher","first-page":"E3492","DOI":"10.1073\/pnas.1604153113","volume":"113","author":"W Zhu","year":"2016","unstructured":"Zhu, W., Gramlich, O. W., Laboissonniere, L., et al. (2016). Transplantation of iPSC-derived TM cells rescues glaucoma phenotypes in vivo. Proc Natl Acad Sci USA, 113(25), E3492\u2013E3500. https:\/\/doi.org\/10.1073\/pnas.1604153113","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10884_CR87","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1167\/iovs.16-20672","volume":"58","author":"W Zhu","year":"2017","unstructured":"Zhu, W., Jain, A., Gramlich, O. W., Tucker, B. A., Sheffield, V. C., & Kuehn, M. H. (2017). Restoration of aqueous humor outflow following transplantation of iPSC-Derived trabecular meshwork cells in a Transgenic mouse model of glaucoma. Invest Ophthalmol Vis Sci, 58(4), 2054\u20132062. https:\/\/doi.org\/10.1167\/iovs.16-20672","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10884_CR88","doi-asserted-by":"publisher","unstructured":"Park, M., Kim, H. M., Shin, H. A., Lee, S. H., Hwang, D. Y., & Lew, H. (2021). Human pluripotent stem cell-Derived neural progenitor cells promote retinal ganglion cell survival and axon recovery in an optic nerve compression animal model.\u00a0International Journal of Molecular Sciences, 20(22). https:\/\/doi.org\/10.3390\/ijms222212529","DOI":"10.3390\/ijms222212529"},{"key":"10884_CR89","doi-asserted-by":"publisher","unstructured":"Shin, H. A., Park, M., Lee, H. J., et al. (2023). Unveiling neuroprotection and regeneration mechanisms in optic nerve injury: Insight from neural progenitor cell therapy with focus on Vps35 and Syntaxin12. Cells, 6(19). https:\/\/doi.org\/10.3390\/cells12192412","DOI":"10.3390\/cells12192412"},{"key":"10884_CR90","doi-asserted-by":"publisher","unstructured":"Liu, K. P., Ma, W., Li, C. Y., & Li, L. Y. (2022). Neurotrophic factors combined with stem cells in the treatment of sciatic nerve injury in rats: a meta-analysis. Bioscience Reports, 42(1), BSR20211399.https:\/\/doi.org\/10.1042\/BSR20211399","DOI":"10.1042\/BSR20211399"},{"issue":"6","key":"10884_CR91","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/14712598.2023.2205017","volume":"23","author":"K Moeinabadi-Bidgoli","year":"2023","unstructured":"Moeinabadi-Bidgoli, K., Mazloomnejad, R., Beheshti Maal, A., Asadzadeh Aghdaei, H., Kazem Arki, M., Hossein-Khannazer, N., & Vosough, M. (2023). Genetic modification and preconditioning strategies to enhance functionality of mesenchymal stromal cells: a clinical perspective. Expert Opinion on Biological Therapy, 23(6), 461\u2013478. https:\/\/doi.org\/10.1080\/14712598.2023.2205017","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10884_CR92","doi-asserted-by":"publisher","first-page":"899657","DOI":"10.3389\/fimmu.2022.899657","volume":"13","author":"DL Eisenson","year":"2022","unstructured":"Eisenson, D. L., Hisadome, Y., & Yamada, K. (2022). Progress in xenotransplantation: Immunologic barriers, advances in gene editing, and successful tolerance induction strategies in pig-to-primate transplantation. Frontiers in Immunology, 13, 899657. https:\/\/doi.org\/10.3389\/fimmu.2022.899657","journal-title":"Frontiers in Immunology"},{"key":"10884_CR93","doi-asserted-by":"publisher","unstructured":"Deng W. L., Gao, M. L., Lei, X. L., Lv, J. N., Zhao, H., He, K. W., Xia, X. X., Li, L. Y., Chen, Y. C., Li, Y. P., Pan, D., Xue, T., & Jin, Z. B. (2018). Gene correction reverses ciliopathy and photoreceptor loss in iPSC-derived retinal organoids from retinitis pigmentosa patients. Stem Cell Reports, 10(4), 1267\u20131281. https:\/\/doi.org\/10.1016\/j.stemcr.2018.02.003. Erratum in: Stem Cell Reports, 10(6), 2005. https:\/\/doi.org\/10.1016\/j.stemcr.2018.05.012","DOI":"10.1016\/j.stemcr.2018.02.003"},{"issue":"23","key":"10884_CR94","doi-asserted-by":"publisher","first-page":"15276","DOI":"10.3390\/ijms232315276","volume":"23","author":"D Benati","year":"2022","unstructured":"Benati, D., Leung, A., Perdigao, P., Toulis, V., van der Spuy, J., & Recchia, A. (2022). Induced pluripotent stem cells and genome-editing tools in determining gene function and therapy for inherited retinal disorders. International Journal of Molecular Sciences, 23(23), 15276. https:\/\/doi.org\/10.3390\/ijms232315276","journal-title":"International Journal of Molecular Sciences"},{"key":"10884_CR95","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ymeth.2021.01.002","volume":"191","author":"Y Long","year":"2021","unstructured":"Long, Y., & Cech, T. R. (2021). Targeted mutagenesis in human iPSCs using CRISPR genome-editing tools. Methods, 191, 44\u201358. https:\/\/doi.org\/10.1016\/j.ymeth.2021.01.002","journal-title":"Methods"},{"issue":"6","key":"10884_CR96","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.stem.2018.05.013","volume":"22","author":"JH Stern","year":"2018","unstructured":"Stern, J. H., Tian, Y., Funderburgh, J., et al. (2018). Regenerating eye tissues to preserve and restore vision. Cell Stem Cell, 22(6), 834\u2013849. https:\/\/doi.org\/10.1016\/j.stem.2018.05.013","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10884_CR97","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/1673-5374.200793","volume":"12","author":"I Aharony","year":"2017","unstructured":"Aharony, I., Michowiz, S., & Goldenberg-Cohen, N. (2017). The promise of stem cell-based therapeutics in ophthalmology. Neural Regen Res, 12(2), 173\u2013180. https:\/\/doi.org\/10.4103\/1673-5374.200793","journal-title":"Neural Regen Res"},{"issue":"5","key":"10884_CR98","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1586\/eop.12.56","volume":"7","author":"KE Kador","year":"2012","unstructured":"Kador, K. E., & Goldberg, J. L. (2012). Scaffolds and stem cells: Delivery of cell transplants for retinal degenerations. Expert Rev Ophthalmol, 7(5), 459\u2013470. https:\/\/doi.org\/10.1586\/eop.12.56","journal-title":"Expert Rev Ophthalmol"},{"issue":"8","key":"10884_CR99","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1007\/s12015-023-10623-0","volume":"19","author":"BS Ajgaonkar","year":"2023","unstructured":"Ajgaonkar, B. S., Kumaran, A., Kumar, S., Jain, R. D., & Dandekar, P. P. (2023). Cell-based therapies for corneal and retinal disorders. Stem Cell Reviews and Reports, 19(8), 2650\u20132682. https:\/\/doi.org\/10.1007\/s12015-023-10623-0","journal-title":"Stem Cell Reviews and Reports"},{"key":"10884_CR100","doi-asserted-by":"publisher","first-page":"1377098","DOI":"10.3389\/fopht.2024.1377098","volume":"4","author":"JS Bellingrath","year":"2024","unstructured":"Bellingrath, J. S., Li, K. V., Aziz, K., Izzi, J. M., Liu, Y. V., & Singh, M. S. (2024). Large animal model species in pluripotent stem cell therapy research and development for retinal diseases: A systematic review. Front Ophthalmol (Lausanne), 4, 1377098. https:\/\/doi.org\/10.3389\/fopht.2024.1377098","journal-title":"Front Ophthalmol (Lausanne)"},{"issue":"7","key":"10884_CR101","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/stem.2377","volume":"34","author":"AM Hoffman","year":"2016","unstructured":"Hoffman, A. M., & Dow, S. W. (2016). Concise review: Stem cell trials using companion animal disease models. Stem Cells, 34(7), 1709\u20131729. https:\/\/doi.org\/10.1002\/stem.2377","journal-title":"Stem Cells"},{"key":"10884_CR102","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fncel.2017.00295","volume":"11","author":"MS Divya","year":"2017","unstructured":"Divya, M. S., Rasheed, V. A., Schmidt, T., Lalitha, S., Hattar, S., & James, J. (2017). Intraocular injection of ES Cell-Derived neural progenitors improve visual function in retinal ganglion Cell-Depleted mouse models. Frontiers in Cellular Neuroscience, 11, 295. https:\/\/doi.org\/10.3389\/fncel.2017.00295","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"10","key":"10884_CR103","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1517\/17460441.2012.714769","volume":"7","author":"A Crooke","year":"2012","unstructured":"Crooke, A., Huete-Toral, F., Mart\u00ednez-\u00c1guila, A., Colligris, B., & Pintor, J. (2012). Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential. Expert Opin Drug Discov, 7(10), 989\u20131001. https:\/\/doi.org\/10.1517\/17460441.2012.714769","journal-title":"Expert Opin Drug Discov"},{"key":"10884_CR104","doi-asserted-by":"publisher","unstructured":"Loiseau, A., Ra\u00eeche-Marcoux, G., Maranda, C., Bertrand, N., & Boisselier, E. (2023). Animal models in eye research: Focus on corneal pathologies. International Journal of Molecular Sciences, 24(23). https:\/\/doi.org\/10.3390\/ijms242316661","DOI":"10.3390\/ijms242316661"},{"issue":"15","key":"10884_CR105","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.21037\/atm-20-4747","volume":"9","author":"I Ahmed","year":"2021","unstructured":"Ahmed, I., Johnston, R. J., Jr., & Singh, M. S. (2021). Pluripotent stem cell therapy for retinal diseases. Ann Transl Med, 9(15), 1279. https:\/\/doi.org\/10.21037\/atm-20-4747","journal-title":"Ann Transl Med"},{"key":"10884_CR106","doi-asserted-by":"publisher","unstructured":"Fields, M., Cai, H., Gong, J., & Del Priore, L. (2016). Potential of induced pluripotent stem cells (iPSCs) for treating Age-Related macular degeneration (AMD). Cells, 5(4). https:\/\/doi.org\/10.3390\/cells5040044","DOI":"10.3390\/cells5040044"},{"issue":"3","key":"10884_CR107","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.scr.2015.02.003","volume":"14","author":"B Mead","year":"2015","unstructured":"Mead, B., Berry, M., Logan, A., Scott, R. A., Leadbeater, W., & Scheven, B. A. (2015). Stem cell treatment of degenerative eye disease. Stem Cell Res, 14(3), 243\u2013257. https:\/\/doi.org\/10.1016\/j.scr.2015.02.003","journal-title":"Stem Cell Res"},{"key":"10884_CR108","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/btt.S290331","volume":"15","author":"A Sharma","year":"2021","unstructured":"Sharma, A., & Jaganathan, B. G. (2021). Stem cell therapy for retinal degeneration: The evidence to date. Biologics, 15, 299\u2013306. https:\/\/doi.org\/10.2147\/btt.S290331","journal-title":"Biologics"},{"issue":"5","key":"10884_CR109","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4274\/tjo.72593","volume":"47","author":"\u00d6 Barut Selver","year":"2017","unstructured":"Barut Selver, \u00d6., Ya\u011fc\u0131, A., E\u011frilmez, S., et al. (2017). Limbal stem cell deficiency and treatment with stem cell transplantation. Turk J Ophthalmol, 47(5), 285\u2013291. https:\/\/doi.org\/10.4274\/tjo.72593","journal-title":"Turk J Ophthalmol"},{"key":"10884_CR110","doi-asserted-by":"publisher","unstructured":"Calonge, M., Nieto-Miguel, T., de la Mata, A., Galindo, S., Herreras, J. M., & L\u00f3pez-Paniagua, M. (2021). Goals and challenges of stem Cell-Based therapy for corneal blindness due to limbal deficiency. Pharmaceutics, 16(9). https:\/\/doi.org\/10.3390\/pharmaceutics13091483","DOI":"10.3390\/pharmaceutics13091483"},{"issue":"3","key":"10884_CR111","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/jfb6030863","volume":"6","author":"A Sehic","year":"2015","unstructured":"Sehic, A., Utheim, \u00d8. A., Ommundsen, K., & Utheim, T. P. (2015). Pre-Clinical cell-Based therapy for limbal stem cell deficiency. J Funct Biomater, 6(3), 863\u2013888. https:\/\/doi.org\/10.3390\/jfb6030863","journal-title":"J Funct Biomater"},{"issue":"6","key":"10884_CR112","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1046\/j.1524-475x.2001.00483.x","volume":"9","author":"JT Daniels","year":"2001","unstructured":"Daniels, J. T., Dart, J. K., Tuft, S. J., & Khaw, P. T. (2001). Corneal stem cells in review. Wound Repair Regen, 9(6), 483\u2013494. https:\/\/doi.org\/10.1046\/j.1524-475x.2001.00483.x","journal-title":"Wound Repair Regen"},{"issue":"11","key":"10884_CR113","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.jcrs.2007.07.020","volume":"33","author":"F Luengo Gimeno","year":"2007","unstructured":"Luengo Gimeno, F., Lavigne, V., Gatto, S., Croxatto, J. O., Correa, L., & Gallo, J. E. (2007). Advances in corneal stem-cell transplantation in rabbits with severe ocular alkali burns. J Cataract Refract Surg, 33(11), 1958\u20131965. https:\/\/doi.org\/10.1016\/j.jcrs.2007.07.020","journal-title":"J Cataract Refract Surg"},{"key":"10884_CR114","doi-asserted-by":"publisher","unstructured":"Yu, Y., Andreev, A. Y., Rogovaya, O. S., et al. (2024). Matrix-Assisted cell transplantation for the treatment of limbal stem cell deficiency in a rabbit model. Biomedicines, 12(1). https:\/\/doi.org\/10.3390\/biomedicines12010101","DOI":"10.3390\/biomedicines12010101"},{"key":"10884_CR115","unstructured":"Yuan, S., & Fan, G. (2015). Stem cell-based therapy of."},{"issue":"4","key":"10884_CR116","doi-asserted-by":"publisher","first-page":"e0125695","DOI":"10.1371\/journal.pone.0125695","volume":"10","author":"J Ma","year":"2015","unstructured":"Ma, J., Guo, C., Guo, C., et al. (2015). Transplantation of human neural progenitor cells expressing IGF-1 enhances retinal ganglion cell survival. PLoS One, 10(4), e0125695. https:\/\/doi.org\/10.1371\/journal.pone.0125695","journal-title":"PLoS One"},{"key":"10884_CR117","doi-asserted-by":"publisher","unstructured":"Zhang, K. Y., Aguzzi, E. A., & Johnson, T. V. (2021). Retinal ganglion cell transplantation: Approaches for overcoming challenges to functional integration. Cells, 10(6). https:\/\/doi.org\/10.3390\/cells10061426","DOI":"10.3390\/cells10061426"},{"issue":"3","key":"10884_CR118","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1111\/aos.13983","volume":"97","author":"S Biswas","year":"2019","unstructured":"Biswas, S., & Wan, K. H. (2019). Review of rodent hypertensive glaucoma models. Acta Ophthalmol, 97(3), e331\u2013e340. https:\/\/doi.org\/10.1111\/aos.13983","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10884_CR119","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ophtha.2023.12.028","volume":"131","author":"MS Humayun","year":"2024","unstructured":"Humayun, M. S., Clegg, D. O., Dayan, M. S., et al. (2024). Long-term Follow-up of a phase 1\/2a clinical trial of a stem Cell-Derived bioengineered retinal pigment epithelium implant for geographic atrophy. Ophthalmology Jun, 131(6), 682\u2013691. https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.028","journal-title":"Ophthalmology Jun"},{"issue":"10","key":"10884_CR120","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.10.10.13","volume":"12","author":"AH Kashani","year":"2021","unstructured":"Kashani, A. H., Lebkowski, J. S., Rahhal, F. M., et al. (2021). One-Year Follow-Up in a phase 1\/2a clinical trial of an allogeneic RPE cell bioengineered implant for advanced dry Age-Related macular degeneration. Transl Vis Sci Technol Aug, 12(10), 13. https:\/\/doi.org\/10.1167\/tvst.10.10.13","journal-title":"Transl Vis Sci Technol Aug"},{"issue":"3","key":"10884_CR121","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/stem.276","volume":"28","author":"S Kolli","year":"2010","unstructured":"Kolli, S., Ahmad, S., Lako, M., & Figueiredo, F. (2010). Successful clinical implementation of corneal epithelial stem cell therapy for treatment of unilateral limbal stem cell deficiency. Stem Cells, 28(3), 597\u2013610. https:\/\/doi.org\/10.1002\/stem.276","journal-title":"Stem Cells"},{"issue":"7\u20138","key":"10884_CR122","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.drudis.2010.02.001","volume":"15","author":"S Ahmad","year":"2010","unstructured":"Ahmad, S., Kolli, S., Lako, M., Figueiredo, F., & Daniels, J. T. (2010). Stem cell therapies for ocular surface disease. Drug Discov Today, 15(7\u20138), 306\u2013313. https:\/\/doi.org\/10.1016\/j.drudis.2010.02.001","journal-title":"Drug Discov Today"},{"issue":"10466","key":"10884_CR123","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/s0140-6736(24)01764-1","volume":"404","author":"T Soma","year":"2024","unstructured":"Soma, T., Oie, Y., Takayanagi, H., et al. (2024). Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: A single-arm, open-label, first-in-human interventional study in Japan. Lancet, 404(10466), 1929\u20131939. https:\/\/doi.org\/10.1016\/s0140-6736(24)01764-1","journal-title":"Lancet"},{"issue":"4","key":"10884_CR124","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2174\/1874467208666150928153511","volume":"9","author":"X Jin","year":"2016","unstructured":"Jin, X., Lin, T., & Xu, Y. (2016). Stem cell therapy and immunological rejection in animal models. Current Molecular Pharmacology, 9(4), 284\u2013288. https:\/\/doi.org\/10.2174\/1874467208666150928153511","journal-title":"Current Molecular Pharmacology"},{"issue":"5","key":"10884_CR125","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/stem.1066","volume":"30","author":"AS Boyd","year":"2012","unstructured":"Boyd, A. S., Rodrigues, N. P., Lui, K. O., Fu, X., & Xu, Y. (2012). Concise review: Immune recognition of induced pluripotent stem cells. Stem Cells, 30(5), 797\u2013803. https:\/\/doi.org\/10.1002\/stem.1066","journal-title":"Stem Cells"},{"issue":"6","key":"10884_CR126","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00281-011-0266-8","volume":"33","author":"R Dressel","year":"2011","unstructured":"Dressel, R. (2011). Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells. Semin Immunopathol, 33(6), 573\u2013591. https:\/\/doi.org\/10.1007\/s00281-011-0266-8","journal-title":"Semin Immunopathol"},{"key":"10884_CR127","doi-asserted-by":"publisher","unstructured":"Ouyang, H., Goldberg, J. L., Chen, S. (2016). Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium.\u00a0International Journal of Molecular Sciences, 17(3):415. https:\/\/doi.org\/10.3390\/ijms17030415","DOI":"10.3390\/ijms17030415"},{"key":"10884_CR128","doi-asserted-by":"publisher","unstructured":"Tomczak, W., Winkler-Lach, W., Tomczyk-Socha, M., & Misiuk-Hoj\u0142o, M. (2023). Advancements in ocular regenerative therapies. Biology (Basel), 19(5). https:\/\/doi.org\/10.3390\/biology12050737","DOI":"10.3390\/biology12050737"},{"issue":"1","key":"10884_CR129","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13287-023-03526-x","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen, X., Xu, N., Li, J., Zhao, M., & Huang, L. (2023). Stem cell therapy for inherited retinal diseases: a systematic review and meta-analysis. Stem Cell Research & Therapy, 14(1), 286. https:\/\/doi.org\/10.1186\/s13287-023-03526-x","journal-title":"Stem Cell Research & Therapy"},{"issue":"8","key":"10884_CR130","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1074\/jbc.R113.509588","volume":"289","author":"ZS Scheiner","year":"2014","unstructured":"Scheiner, Z. S., Talib, S., & Feigal, E. G. (2014). The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies. The Journal of Biological Chemistry, 289(8), 4571\u20134577. https:\/\/doi.org\/10.1074\/jbc.R113.509588","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10884_CR131","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-023-01873-0","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi, M., Behdarvand Dehkordi, F., Chehelgerdi, M., Kabiri, H., Salehian-Dehkordi, H., Abdolvand, M., Salmanizadeh, S., Rashidi, M., Niazmand, A., Ahmadi, S., Feizbakhshan, S., Kabiri, S., Vatandoost, N., & Ranjbarnejad, T. (2023). Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy. Molecular Cancer, 22(1), 189. https:\/\/doi.org\/10.1186\/s12943-023-01873-0","journal-title":"Molecular Cancer"},{"key":"10884_CR132","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.omtn.2017.09.009","volume":"9","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z., Zhang, Y., Gao, F., et al. (2017). CRISPR\/Cas9 Genome-Editing system in human stem cells: Current status and future prospects. Mol Ther Nucleic Acids, 9, 230\u2013241. https:\/\/doi.org\/10.1016\/j.omtn.2017.09.009","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"10884_CR133","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41433-022-02169-1","volume":"37","author":"X Hu","year":"2023","unstructured":"Hu, X., Zhang, B., Li, X., et al. (2023). The application and progression of CRISPR\/Cas9 technology in ophthalmological diseases. Eye (Lond), 37(4), 607\u2013617. https:\/\/doi.org\/10.1038\/s41433-022-02169-1","journal-title":"Eye (Lond)"},{"issue":"2","key":"10884_CR134","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","volume":"25","author":"GX Ruan","year":"2017","unstructured":"Ruan, G. X., Barry, E., Yu, D., Lukason, M., Cheng, S. H., & Scaria, A. (2017). CRISPR\/Cas9-Mediated genome editing as a therapeutic approach for leber congenital amaurosis 10. Mol Ther, 25(2), 331\u2013341. https:\/\/doi.org\/10.1016\/j.ymthe.2016.12.006","journal-title":"Mol Ther"},{"key":"10884_CR135","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fimmu.2012.00296","volume":"3","author":"I Benhar","year":"2012","unstructured":"Benhar, I., London, A., & Schwartz, M. (2012). The privileged immunity of immune privileged organs: The case of The eye. Frontiers in Immunology, 3, 296. https:\/\/doi.org\/10.3389\/fimmu.2012.00296","journal-title":"Frontiers in Immunology"},{"issue":"7631","key":"10884_CR136","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K., Tsunekawa, Y., Hernandez-Benitez, R., et al. (2016). In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature, 540(7631), 144\u2013149. https:\/\/doi.org\/10.1038\/nature20565","journal-title":"Nature"},{"issue":"7341","key":"10884_CR137","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nature09941","volume":"472","author":"M Eiraku","year":"2011","unstructured":"Eiraku, M., Takata, N., Ishibashi, H., et al. (2011). Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature, 472(7341), 51\u201356. https:\/\/doi.org\/10.1038\/nature09941","journal-title":"Nature"},{"issue":"4","key":"10884_CR138","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.stemcr.2016.03.001","volume":"6","author":"M V\u00f6lkner","year":"2016","unstructured":"V\u00f6lkner, M., Zsch\u00e4tzsch, M., Rostovskaya, M., et al. (2016). Retinal organoids from pluripotent stem cells efficiently recapitulate retinogenesis. Stem Cell Reports, 6(4), 525\u2013538. https:\/\/doi.org\/10.1016\/j.stemcr.2016.03.001","journal-title":"Stem Cell Reports"},{"key":"10884_CR139","doi-asserted-by":"publisher","first-page":"204173142311977","DOI":"10.1177\/20417314231197793","volume":"14","author":"L Balters","year":"2023","unstructured":"Balters, L., & Reichl, S. (2023). 3D Bioprinting of corneal models: A review of the current state and future outlook. J Tissue Eng, 14, 20417314231197790. https:\/\/doi.org\/10.1177\/20417314231197793","journal-title":"J Tissue Eng"},{"key":"10884_CR140","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biomaterials.2018.04.034","volume":"171","author":"A Sorkio","year":"2018","unstructured":"Sorkio, A., Koch, L., Koivusalo, L., et al. (2018). Human stem cell based corneal tissue mimicking structures using laser-assisted 3D Bioprinting and functional Bioinks. Biomaterials, 171, 57\u201371. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.04.034","journal-title":"Biomaterials"},{"issue":"1","key":"10884_CR141","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12951-023-01992-2","volume":"21","author":"S Li","year":"2023","unstructured":"Li, S., Chen, L., & Fu, Y. (2023). Nanotechnology-based ocular drug delivery systems: Recent advances and future prospects. J Nanobiotechnology, 21(1), 232. https:\/\/doi.org\/10.1186\/s12951-023-01992-2","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"10884_CR142","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1021\/acs.molpharmaceut.0c00224","volume":"18","author":"Q Li","year":"2021","unstructured":"Li, Q., Weng, J., Wong, S. N., Thomas Lee, W. Y., & Chow, S. F. (2021). Nanoparticulate drug delivery to the retina. Mol Pharm, 18(2), 506\u2013521. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00224","journal-title":"Mol Pharm"},{"issue":"12","key":"10884_CR143","doi-asserted-by":"publisher","first-page":"8959","DOI":"10.1021\/acsomega.7b01604","volume":"2","author":"SY Chan","year":"2017","unstructured":"Chan, S. Y., Chan, B. Q. Y., Liu, Z., et al. (2017). Electrospun Pectin-Polyhydroxybutyrate nanofibers for retinal tissue engineering. ACS Omega, 2(12), 8959\u20138968. https:\/\/doi.org\/10.1021\/acsomega.7b01604","journal-title":"ACS Omega"},{"issue":"1","key":"10884_CR144","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/iio.0000000000000298","volume":"60","author":"GW Armstrong","year":"2020","unstructured":"Armstrong, G. W., & Lorch, A. C. (2020). A(eye): A review of current applications of artificial intelligence and machine learning in ophthalmology. Int Ophthalmol Clin Winter, 60(1), 57\u201371. https:\/\/doi.org\/10.1097\/iio.0000000000000298","journal-title":"Int Ophthalmol Clin Winter"},{"key":"10884_CR145","doi-asserted-by":"publisher","first-page":"657525","DOI":"10.3389\/fvets.2021.657525","volume":"8","author":"F Nowzari","year":"2021","unstructured":"Nowzari, F., Wang, H., Khoradmehr, A., et al. (2021). Three-Dimensional imaging in stem Cell-Based researches. Front Vet Sci, 8, 657525. https:\/\/doi.org\/10.3389\/fvets.2021.657525","journal-title":"Front Vet Sci"},{"issue":"1","key":"10884_CR146","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.survophthal.2021.03.003","volume":"67","author":"D Benet","year":"2022","unstructured":"Benet, D., & Pellicer-Valero, O. J. (2022). Artificial intelligence: The unstoppable revolution in ophthalmology. Surv Ophthalmol, 67(1), 252\u2013270. https:\/\/doi.org\/10.1016\/j.survophthal.2021.03.003","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"10884_CR147","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMp1613723","volume":"376","author":"PW Marks","year":"2017","unstructured":"Marks, P. W., Witten, C. M., & Califf, R. M. (2017). Clarifying Stem-Cell therapy\u2019s benefits and risks. N Engl J Med, 376(11), 1007\u20131009. https:\/\/doi.org\/10.1056\/NEJMp1613723","journal-title":"N Engl J Med"},{"issue":"1","key":"10884_CR148","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40545-021-00311-0","volume":"14","author":"V Ronco","year":"2021","unstructured":"Ronco, V., Dilecce, M., Lanati, E., Canonico, P. L., & Jommi, C. (2021). Price and reimbursement of advanced therapeutic medicinal products in Europe: Are assessment and appraisal diverging from expert recommendations? J Pharm Policy Pract, 14(1), 30. https:\/\/doi.org\/10.1186\/s40545-021-00311-0","journal-title":"J Pharm Policy Pract"},{"issue":"3","key":"10884_CR149","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrm.2016.10","volume":"17","author":"A Trounson","year":"2016","unstructured":"Trounson, A., & DeWitt, N. D. (2016). Pluripotent stem cells progressing to the clinic. Nat Rev Mol Cell Biol, 17(3), 194\u2013200. https:\/\/doi.org\/10.1038\/nrm.2016.10","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10884_CR150","doi-asserted-by":"publisher","first-page":"698521","DOI":"10.3389\/fmed.2021.698521","volume":"8","author":"J Hern\u00e1ndez-Ju\u00e1rez","year":"2021","unstructured":"Hern\u00e1ndez-Ju\u00e1rez, J., Rodr\u00edguez-Uribe, G., & Borooah, S. (2021). Toward the treatment of inherited diseases of the retina using CRISPR-Based gene editing. Front Med (Lausanne), 8, 698521. https:\/\/doi.org\/10.3389\/fmed.2021.698521","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10884_CR151","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1210\/er.2008-0031","volume":"30","author":"B Lo","year":"2009","unstructured":"Lo, B., & Parham, L. (2009). Ethical issues in stem cell research. Endocr Rev, 30(3), 204\u2013213. https:\/\/doi.org\/10.1210\/er.2008-0031","journal-title":"Endocr Rev"},{"issue":"6414","key":"10884_CR152","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.362.6414.513","volume":"362","author":"J Kaiser","year":"2018","unstructured":"Kaiser, J. (2018). Suspect science leads to pause in stem cell trial. Science, 362(6414), 513. https:\/\/doi.org\/10.1126\/science.362.6414.513","journal-title":"Science"},{"issue":"1","key":"10884_CR153","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/biot.201400348","volume":"10","author":"MJ Jenkins","year":"2015","unstructured":"Jenkins, M. J., & Farid, S. S. (2015). Human pluripotent stem cell-derived products: Advances towards robust, scalable and cost-effective manufacturing strategies. Biotechnol J, 10(1), 83\u201395. https:\/\/doi.org\/10.1002\/biot.201400348","journal-title":"Biotechnol J"},{"key":"10884_CR154","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Paniagua, M., de la Mata, A., Galindo, S., Bl\u00e1zquez, F., Calonge, M., & Nieto-Miguel, T. (2021). Advanced therapy medicinal products for the eye: Definitions and regulatory framework. Pharmaceutics, 6(3). https:\/\/doi.org\/10.3390\/pharmaceutics13030347","DOI":"10.3390\/pharmaceutics13030347"},{"issue":"2","key":"10884_CR155","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4252\/wjsc.v7.i2.448","volume":"7","author":"PX Wan","year":"2015","unstructured":"Wan, P. X., Wang, B. W., & Wang, Z. C. (2015). Importance of the stem cell microenvironment for ophthalmological cell-based therapy. World Journal of Stem Cells, 7(2), 448\u2013460. https:\/\/doi.org\/10.4252\/wjsc.v7.i2.448","journal-title":"World Journal of Stem Cells"},{"issue":"8","key":"10884_CR156","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.stemcr.2023.05.003","volume":"18","author":"T Hirai","year":"2023","unstructured":"Hirai, T., Yasuda, S., Umezawa, A., & Sato, Y. (2023). Country-specific regulation and international standardization of cell-based therapeutic products derived from pluripotent stem cells. Stem Cell Reports, 18(8), 1573\u20131591. https:\/\/doi.org\/10.1016\/j.stemcr.2023.05.003","journal-title":"Stem Cell Reports"},{"key":"10884_CR157","doi-asserted-by":"publisher","unstructured":"Hameed, S. S., & Sharma, T. P. (2025). Generation of retinal ganglion cells from reprogrammed keratocytes of non-glaucoma and glaucoma donors. Current Protocols, 5(1), e70091. https:\/\/doi.org\/10.1002\/cpz1.70091","DOI":"10.1002\/cpz1.70091"},{"issue":"6","key":"10884_CR158","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1167\/iovs.17-23646","volume":"59","author":"BT McLelland","year":"2018","unstructured":"McLelland, B. T., Lin, B., Mathur, A., et al. (2018). Transplanted hESC-Derived retina organoid sheets differentiate, integrate, and improve visual function in retinal degenerate rats. Invest Ophthalmol Vis Sci, 59(6), 2586\u20132603. https:\/\/doi.org\/10.1167\/iovs.17-23646","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"17","key":"10884_CR159","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1089\/scd.2019.0090","volume":"28","author":"RK Singh","year":"2019","unstructured":"Singh, R. K., Occelli, L. M., Binette, F., Petersen-Jones, S. M., & Nasonkin, I. O. (2019). Transplantation of human embryonic stem cell-derived retinal tissue in the subretinal space of the Cat eye. Stem Cells and Development, 28(17), 1151\u20131166. https:\/\/doi.org\/10.1089\/scd.2019.0090","journal-title":"Stem Cells and Development"},{"issue":"9\u201310","key":"10884_CR160","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/scd.2023.0257","volume":"33","author":"B Lin","year":"2024","unstructured":"Lin, B., Singh, R. K., Seiler, M. J., & Nasonkin, I. O. (2024). Survival and functional integration of human embryonic stem cell-derived retinal organoids after shipping and transplantation into retinal degeneration rats. Stem Cells and Development, 33(9\u201310), 201\u2013213. https:\/\/doi.org\/10.1089\/scd.2023.0257","journal-title":"Stem Cells and Development"},{"issue":"3","key":"10884_CR161","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/jop.2020.0016","volume":"37","author":"BT McLelland","year":"2021","unstructured":"McLelland, B. T., Lin, B., Mathur, A., Aramant, R. B., Thomas, B. B., Nistor, G., Keirstead, H. S., & Seiler, M. J. (2021). Transplanted hESC-derived retina organoid sheets differentiate, integrate, and improve visual function in retinal degenerate rats. Journal of Ocular Pharmacology and Therapeutics, 37(3), 147\u2013156. https:\/\/doi.org\/10.1089\/jop.2020.0016","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10884_CR162","doi-asserted-by":"publisher","unstructured":"Occelli, L. M., Marinho, F., Singh, R. K., Binette, F., Nasonkin, I. O., & Petersen-Jones, S. M. (2021). Subretinal transplantation of human embryonic stem cell-derived retinal tissue in a feline large animal model. Journal of Visualized Experiments, (174), e61683. https:\/\/doi.org\/10.3791\/61683","DOI":"10.3791\/61683"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10884-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-10884-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10884-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:01:55Z","timestamp":1757160115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-10884-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":162,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10884"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-10884-x","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"8 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study does not involve human participants, human data or human tissue.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study does not involve individual data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}]}}